Twenty-five years after chernobyl: Outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 7, 2013, Pages 3039-3048

  Reiners, Christoph ^a   Biko, Johannes ^a   Haenscheid, Heribert ^a   Hebestreit, Helge ^a   Kirinjuk, Stalina ^b   Baranowski, Oleg ^b   Marlowe, Robert J ^c   Demidchik, Ewgeni ^d   Drozd, Valentina ^e   Demidchik, Yuri ^f  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Hospital for Oncology   (Belarus)

^c Spencer Fountayne Corporation   (United States)

^d INSTITUTE FOR MATHEMATICS   (Belarus)

^e Intl Belarusian German Foundation Help for Radiation Induced Thyroid Cancer Patients: Arnica   (Belarus)

^f BELARUSIAN MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; IODINE 131; THYROGLOBULIN;

ADVANCED CANCER; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CAUSE OF DEATH; CHERNOBYL ACCIDENT; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE SURVEILLANCE; DOSIMETRY; FEMALE; FOLLOW UP; GERMANY; HIGH RISK PATIENT; HUMAN; LUNG FIBROSIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION INJURY; RISK ASSESSMENT; RISK FACTOR; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME; WHOLE BODY RADIATION;

ADOLESCENT; CARCINOMA; CHERNOBYL NUCLEAR ACCIDENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; IODINE RADIOISOTOPES; MALE; NEOPLASMS, RADIATION-INDUCED; RADIOPHARMACEUTICALS; REMISSION INDUCTION; REPUBLIC OF BELARUS; RISK; THYROID GLAND; THYROID NEOPLASMS;

EID: 84879927404     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1059     Document Type: Article

References (40)

1. Bennett B, Repacholi M, Carr Z. Health effects of the Chernobyl accident and special health care programmes. Report of the UN Chernobyl Forum expert group "Health." Geneva: World Health Organization; 2006.
2. Cardis E, Howe G, Ron E, et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot. 2006;26:127-140. (Pubitemid 43861071)
3. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 2008 report to the general assembly with scientific annexes, Volume II, Annex D: Health effects due to radiation from the Chernobyl accident. New York: United Nations; 2011.
4. Balonov M. Third annual Warren K Sinclair keynote address: retrospective analysis of impacts of the Chernobyl accident. Health Phys. 2007;93:383-409. (Pubitemid 350287263)
5. Demidchik YE, Saenko VA, Yamashita S. Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present. Arq Bras Endocrinol Metab. 2007;51:748-762.
6. Ron E. Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys. 2007;93:502-511. (Pubitemid 350287273)
7. Williams D. Twenty years' experience with post-Chernobyl thyroid cancer. Best Pract Res Clin Endocrinol Metab. 2008;22:1061-1073.
8. Surveillance, Epidemiology, and End Results (SEER) Program. SEER research data (1992-2007), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, based on the November 2009 submission. (www.seer.cancer.gov). Released April 2010.
9. Demidchik YE, Demidchik EP, Reiners C, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg. 2006;243:525-532.
10. Reiners C, Demidchik YE, Drozd VM, Biko J. Thyroid cancer in infants and adolescents after Chernobyl. Minerva Endocrinol. 2008;33:381-395.
11. Reiners C. Radioactivity and thyroid cancer. Hormones (Athens). 2009;8:185-191.
12. Hebestreit H, Biko J, Drozd V, et al. Pulmonary fibrosis in youth with juvenile thyroid cancer after Chernobyl. Eur J Nucl Med Mol Imag. 2011;38:1683-1690.
13. Franzius C, Dietlein M, Biermann M, et al. Procedure guideline for radioiodine therapy and I-131 iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer. Nuklearmedizin. 2007;46:224-231. (Pubitemid 47612290)
14. Luster M, Lassmann M, Freudenberg LS, Reiners C. Thyroid cancer in childhood: management strategy, including dosimetry and long-term results. Hormones (Athens). 2007;6:269-278.
15. Farahati J, Demidchik EP, Biko J, Reiners C. Inverse association between age at the time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinoma in Belarus. Cancer. 2000;88:1470-1476. (Pubitemid 30155187)
16. Higashi T, Nishii R, Yamada S, et al. Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases. J Nucl Med. 2011;52:683-689.
17. Reiners C. Radioiodine therapy in patients with pulmonary metastases of thyroid cancer: when to treat, when not to treat? Eur J Nucl Med Mol Imaging. 2003;30:939-942. (Pubitemid 37086934)
18. Pawelczak M, David R, Franklin B, et al. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following I-131 treatment: a systematic review. Thyroid. 2010;20:1095-1101.
19. Biko J, Reiners C, Kreissl MC, et al. Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years' follow-up. Eur J Nucl Med Mol Imaging. 2011;38:651-705.
20. Kumagai A, Reiners C, Drozd V, Yamashita S. Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management. Endocr J. 2007;54:839-847. (Pubitemid 351346765)
21. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley Liss; 2002.
22. Schlumberger M, De Vathaire F, Travagli JP, et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab. 1987;65:1088-1094. (Pubitemid 18026839)
23. Zimmerman D, Hay ID, Gough IR, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988;104:1157-1166. (Pubitemid 19012000)
24. Dottorini ME, Vignati A, Mazzucchelli L, et al. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med. 1997;38:669-675. (Pubitemid 27204036)
25. Vassilopoulo-Sellin R, Goepfert H, Raney B, Schultz PN. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up. Head Neck. 1998;20:549-555. (Pubitemid 28361461)
26. Segal K, Shvero J, Stern Y, Mechlis S, et al. Surgery of thyroid cancer in children and adolescents. Head Neck. 1998;20:293-297. (Pubitemid 28183682)
27. Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg. 1998;227:533-541. (Pubitemid 28363270)
28. La Quaglia MP, Black T, Holcomb GW 3rd, et al. Differentiated thyroid cancer: clinical characteristics, treatment and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg. 2000;35:955-959.
29. Jarzab B, Handkiewicz-Junak D, Wloch J, et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med. 2000;27:833-841. (Pubitemid 30456766)
30. Grigsby PW, Galor A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer. 2002;95:724-729. (Pubitemid 34839662)
31. Chow SM, Law SC, Mendenhall WM, et al. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Pediatr Blood Cancer. 2004;42:176-183. (Pubitemid 38173929)
32. Popovtzer A, Shpitzer T, Bahar G, et al. Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol Head Neck Surg. 2006;135:581-584. (Pubitemid 44468135)
33. Handkiewicz-Junak D, Wloch J, Roskosz J, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med. 2007;48:879-888. (Pubitemid 46909915)
34. Wada N, Sugino K, Mimura T, et al. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol. 2009;16:3442-3449.
35. Hay ID, Gonzalez-Losada T, Reinalda MS, et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34:1192-1202.
36. Vaisman F, Bulzico DA, Cordeiro et al. Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer. Cinics (São Paulo). 2011;66:281-286.
37. Rybakov SJ, Komissarenko IV, Tronko ND, et al. Thyroid cancer in children of Ukraine after the Chernobyl accident. World J Surg. 2000;24:1446-1449.
38. Drozd V, Shaverda E, Leonova T, Biko J, Reiners C. The pituitary-gonadal system in children and adolescents from Belarus after treatment for differentiated thyroid cancer after Chernobyl. Paper presented at: 12th International Congress of Endocrinology, August 31 through September 4, 2004; Lisbon, Portugal, MEDIMOND, 989-995.
39. Verburg FA, Biko J, Dießl S, et al. I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer, J Clin Endocrinol Metab. 2011;96:1268-1270.
40. World Health Organization. Preliminary dose estimation from the nuclear accident after the 2011 great east Japan earthquake and tsunami. Geneva: World Health Organization; 2012. Reactor Safety Children"